Emergent BioSolutions up after authorizing $50 million stock repurchase plan
31/03/2025 15:11
** Shares of Maryland-based drugmaker Emergent BioSolutions EBS.N rise 11.8% to $5.21 ** EBS authorizes the repurchase of up to $50 million of the company's common stock on or before March 27, 2026 ** EBS has 54.3 million outstanding shares, with a market capitalization of $253.2 million according to data compiled by LSEG ** As of last close, EBS has risen 84% in the past 12 months (Reporting by Siddhi Mahatole) ((siddhi.mahatole@thomsonreuters.com))